Catalogue Number
BN-O1520
Analysis Method
HPLC,NMR,MS
Specification
98%(HPLC)
Storage
-20℃
Molecular Weight
286.3
Appearance
Orange cryst.
Botanical Source
This product is isolated and purified from the roots of Lindera aggregata (Sims) Kosterm
Structure Type
Chalcones
Category
Standards;Natural Pytochemical;API
SMILES
CCCCCCCC=CCC(=O)C
Synonyms
2-[(2E)-1-Hydroxy-3-phenyl-2-propen-1-ylidene]-4,5-dimethoxy-4-cyclopentene-1,3-dione/Linderone/4-Cyclopentene-1,3-dione, 2-[(2E)-1-hydroxy-3-phenyl-2-propen-1-ylidene]-4,5-dimethoxy-
IUPAC Name
(E)-dodec-4-en-2-one
Density
1.3±0.1 g/cm3
Solubility
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Flash Point
207.4±23.6 °C
Boiling Point
547.7±50.0 °C at 760 mmHg
Melting Point
InChl
InChI=1S/C12H22O/c1-3-4-5-6-7-8-9-10-11-12(2)13/h9-10H,3-8,11H2,1-2H3/b10-9+
InChl Key
SNSAFZXASVXYNM-MDZDMXLPSA-N
WGK Germany
RID/ADR
HS Code Reference
2914190000
Personal Projective Equipment
Correct Usage
For Reference Standard and R&D, Not for Human Use Directly.
Meta Tag
provides coniferyl ferulate(CAS#:1782-79-2) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate
No Technical Documents Available For This Product.
29139962
Farther Remarks on the Method of Treating the Remittent Fevers of the West Indies; with Observations on the Best Means of Preserving Health in Jamaica
1782 Jan-Mar
29139963
A Table of the Greatest, Least, and Mean Heights of the Thermometer and Barometer, and of the Fall of Rain in London in 1780
1782 Jan-Mar;
10206293
A range of measures have been proposed to enhance the provision of information to cancer patients and randomized controlled trials have demonstrated their impact on patient satisfaction and recall. The current study explored the practice and views of oncologists, surgeons and general practitioners (GPs) with regards to providing patients with consultation audiotapes and summary letters. In stage 1, 28 semi-structured interviews with doctors were conducted to provide qualitative data on which to base a questionnaire. In stage 2, 113 medical oncologists, 43 radiation oncologists, 55 surgeons and 108 GPs completed questionnaires. Only one-third of doctors had ever provided patients with a copy of the letter written to the oncologist or referring doctor, and one-quarter had provided a summary letter or tape. The majority of doctors were opposed to such measures; however, a substantial minority were in favour of providing a letter or tape under certain conditions. More surgeons and GPs (> two-thirds) were opposed to specialists providing a consultation audiotape than oncologists (one-third). Gender, years of experience and attitude to patient involvement in decision-making were predictive of doctors’ attitudes. The majority of doctors remain opposed to offering patients personalized information aids. However, practice and perspectives appear to be changing. © 1999 Cancer Research Campaign
Dr-pt communication, information provision, audiotapes, patient letters
Audiotapes and letters to patients: the practice and views of oncologists, surgeons and general practitioners
D McConnell,1 P N Butow,1 and M H N Tattersall2
1999 Apr;
Description :
Empty ...